Enhanced Antisense Oligonucleotide Delivery Using Cationic Liposomes Grafted with Trastuzumab: A Proof-of-Concept Study in Prostate Cancer

• Príomhchruthaitheoirí: Guillaume Sicard (Údar), Clément Paris (Údar), Sarah Giacometti (Údar), Anne Rodallec (Údar), Joseph Ciccolini (Údar), Palma Rocchi (Údar), Raphaëlle Fanciullino (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: MDPI AG, 2020-11-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

Prostate cancer (PCa) is the second most common cancer in men worldwide and the fifth leading cause of death by cancer. The overexpression of TCTP protein plays an important role in castration resistance. Over the last decade, antisense technology has emerged as a rising strategy in oncology. Using...